LGND Ligand Pharmaceuticals, Inc.
$286.85 -0.03%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-0.03%
YTD
+51.70%
P/E
111.53
P/B
3.66
ROE
5.2%
Div yield
—
Beta
0.88
Market cap
$5.7B
RSI (14)
39
Next earnings
Feb 24, 2027
Same sector · Health Care
Compare LGND with NVO and JNJ →Follow LGND in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$285.21
Close
$286.85
Day high
$291.36
Day low
$282.36
Volume
260K
Latest headlines
Ligand Pharmaceuticals (LGND) Stock May Be A Bargain On Royalty Cash Flows
Yahoo Finance · Nov 20
Ligand Pharmaceuticals Sees Strong Royalty Growth Ahead of Investor Day, Oppenheimer Says
Yahoo Finance · Oct 30
Ligand Pharmaceuticals (LGND) Stock Price Ignores Q3 Earnings Losses And Royalty Strength
Yahoo Finance · Oct 30
Ligand (LGND) Q3 2026 Earnings Call Transcript
Yahoo Finance · Oct 30
What Ligand Pharmaceuticals (LGND) Said on Its Q3 Earnings Call
Yahoo Finance · Oct 29
Ligand: Q3 Earnings Snapshot
Yahoo Finance · Oct 29
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Oct 30, 2026 View → 8-K Oct 29, 2026 View → 8-K Sep 24, 2026 View → 8-K Sep 22, 2026 View → 10-Q Aug 7, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell LGND. Try it in the Lab to size a position and see the risk.